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Abstract 
 
Breast cancer incidence rate has increased in the 5 recent years with 14% increases in mortality. The structural change in the 
collagen chain has led to alterations in the cancer cells. Various biological processes, such as differentiation or gene 
expression, are regulated through extracelullar matrix (ECM)[1]. The restructuring of the collagenous architecture in the 
hypoxic microenvironment may influence the invasive growth of the cancer cells. With the increased stress within the cell, the 
invasion of cancer cells into the ECM was triggered. This cell lines model would enable the exploration of the relationship 
between the extracellular matrices component and the tumor proliferation. The aim of this study is to characterize the 
collagen (IV) mRNA expression in the breast cancer cell.  Breast cancer (MCF7) cell lines were cultured and harvested upon 
confluent. The RNA was extracted from the cell lines and then the cDNA were synthesized. The collagen (IV) mRNA levels in 
breast cancer cell lines were measured using real time PCR and GAPDH was used as an internal control. The level of COL4A2 
(IV) mRNA expression was higher compared with COL4A1 (IV) mRNA. The level of COL4A5 (IV) mRNA was reduced 
significantly in breast cancer cells lines. Overall, the expression of COL4A1-A6 (IV) was reduced. The reduced amount of 
collagen (IV) in breast cancer cell lines suggested that the collagen was restructured and this has triggered the tumor invasion 
into the ECM.  
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1.0  INTRODUCTION 
 
Breast cancer is the most common cancer which 
causes death in women worldwide [2]. The incidence 
of breast cancer has increased more than 20% with 
14% increases in mortality in five recent years. Among 
the general population in Malaysia, occurrence of 
breast cancer is within the highest statistics of five 
leading cancers [3].  
Breast structure is composed of epithelial and 
stromal components. The ductal-lobular system in 
breast is made up of a dual layer of epithelial resting 
on a basement membrane enveloped by the 
extracellular matrix (ECM) and stromal cell. While, the 
mammary glands of the breast consist of a complex 
interaction network of laminin, fibronectin and 
collagen which responsible for the development and 
functioning of the organ [4].   
Basement membranes is a thin layer sheet of fiber 
that underlies the epithelium or endothelium, which 
composed of collagen IV, laminin, sulfate 
proteoglycan and fibronectin [5]. The deposition of 
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ECM structure gives support on which epithelial and 
endothelial cells resides [6]. The ECM and basement 
membranes are extensively cross-linked for it to 
function. Hence, the remodeling of the ECM may 
lead to cancer.  
Restructuring of collagenous architecture in the 
hypoxic microenvironment may influence invasive 
growth of cancer cells. This is because, collagens 
and laminin undergone independent intermolecular 
self- assembly to form a sheet-like structure that 
interacts with each other [7]. Cancer cells are 
stimulated to secrete lysyl oxidase that triggered 
collagen type IV crosslinking cascades as the tumor 
mass expanded [8, 9]. This process produced 
irregular, dense and sheet-like deposition at 
basement membrane [10] (which undergoes a series 
of structural changes based on type IV collagen 
uncoiling for degradation and this facilitates 
tumorigenesis [11]. 
The stiffness of the tissues enhanced the 
proliferation, invasion and migration of the cancer 
cells and tumor angiogenesis [12]. In the extracellular 
matrix (ECM), the stress increased, triggering the 
invasion of cancer cells into ECM to reduce the stress. 
The secretion of matrix metalloproteinase by cancer 
cells along with uncoiling of collagen triple helix 
caused collagen degradation into fragment at 
invasion front [13]. The shedding of cancer cells 
formed new cluster protrusions as the collagen 
disappeared. On the other hand, the involvement of 
lysyl oxidase will increase the stiffness of tissues in ECM 
[14]. The stiff and rigid of collagen type IV act as 
highway for cancer cells migration.  
Mutations and interruptions in collagen type IV 
chains have been shown to cause diseases. The 
inheritance of X-linked mutation in COL4A5 gene or 
in autosomal recessive patients, either heterozygous 
or homozygous mutations in COL4A3 and COL4A4 
caused Alport’s Syndrome [15]. In addition, diffuse 
leiomyomatosis are reported to cause by deletions 
involving the adjacent COL4A5 and COL4A6 genes 
[16].  
Type IV collagen is a member of the collagen 
superfamily that contains 29 different triple helical 
molecules assembled from 42 genetically distinct  
chains Collagen is classified into nine subfamilies 
based on their supramolecular organization and 
other features [17, 18, 19] To date, extensive studies 
have been focusing on collagen type VI that has a 
similar structural features and roles as collagen type 
IV [20.21]. It has been shown that the collagen VI was 
upregulated in breast cancer, generating a 
microenvironment that promotes tumour progression 
and metastasis in breast and was recognized as a 
potential biomarker for cancer diagnosis [22, 23].  
Yet, little is known about the expression of type IV 
collagen in breast cancer cells. Therefore, we used 
real time qPCR to identify the expression of type IV 
collagens mRNA in breast cancer.   
 
 
 
2.0  EXPERIMENTAL 
 
2.1  Samples 
 
The breast adenocarcinoma cell line, Michigan 
Cancer Foundation-7 (MCF 7) was obtained from 
ATCC® HTB-22 (ATCC, Virginia) and the fibroblast cell 
line was obtained from Research Laboratory of Kulliyah 
of Pharmacy, IIUM, Kuantan. The complete growth 
medium (CGM) used to expand the cell lines of breast 
cancer and fibroblast and harvested upon 
confluence. 
 
2.2  RNA Extraction and cDNA Synthesis  
 
The RNA was extracted using RNeasy Mini kit 
according to manufacturer instructions (Qiagen). The 
purified mRNA of the ratio of absorbance at 260/280 
equal to 2.0 was selected and subjected to 
complementary DNA (cDNA) synthesis by using 
SensiFAST cDNA synthesis Kit (Bioline) following the 
manufacturer’s protocol. The cDNA obtained were 
then used in the qPCR. 
 
2.3  Real Time PCR (qPCR)  
 
PCR amplification and detection were performed 
using the CFX96 qPCR machine, C1000 Touch® 
Thermal Cycler (Bio-Rad, USA). Briefly, each qPCR 
reaction comprised 5μl of 2x SensiFAST SYBR® & 
Fluorescein Kit (Bioline), 0.7μl of each 20ng/μl sense 
and antisense primer and 2μl of 100ng/μl cDNA 
template, made up to a total volume of 10μl. The 
gene for GAPDH was amplified in parallel as an 
internal control. The levels of collagen type IV α1 to 
α6 mRNA were compared in breast cancer cell lines. 
The primer pairs were optimized before the 
amplications. The assays were done in triplicate and 
also run in two separate experiments. 
  
 
3.0  RESULTS AND DISCUSSION 
 
3.1  Collagen Type IV mRNA Expression in Breast 
Cancer Cell Lines  
 
The study observed α1(IV), α2(IV), and low levels of 
α4(IV) and α6(IV) in breast cancer cell lines (Table 1 
and Figure 1). The level of α3(IV) and α5(IV) could not 
be observed. This is consistent with the collagen 
distribution in the mammary gland of breast. In 
normal breast, α1(IV) and α2(IV) were found in all 
basement membrane whereas the distribution of 
α3(IV), α4(IV), α5(IV) and α6(IV) were restricted to 
certain area [24]. The α5(IV) and α6(IV) were 
localized in the basement membrane of the 
mammary gland in a linear pattern, but form a 
second network in the membrane of cancer 
cells[25].  
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Table 1 Intra- and inter-assay coefficients of variation for 
mRNA quantitation of COL4A1-COL4A6 (IV) in breast 
cancer cell lines 
 
Collagen 
type IV  
CV of intra-assay (%) CV of inter-assay 
(%) 
COL4A1 3.11 2.09 
COL4A2 1.97 2.02 
COL4A3 9.11 0.38 
COL4A4 5.75 5.22 
COL4A5 2.44 2.48 
COL4A6 3.17 3.54 
GAPDH 1.34 1.22 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1 Collagen type IV mRNA expression in breast cancer 
cell lines (MCF-7) corresponding to COL4A1-COL4A6 
 
 
This study has characterized the mRNA expression 
of collagen type IV in breast cancer cells with the use 
of real-time PCR for quantification. The intra- and 
inter-assay value of correlation coefficients (%CV) of 
the real time assay of breast cancer cell line were 
less than 10% based on Cq-value. The value obtained 
show that the quantification of mRNA was highly 
reproducible [26].   
It was found in the study that the level of expression 
for α2(IV), α4(IV) and α6(IV) was lower when 
compared to α1(IV). Lack of studies focusing in 
quantification of the collagen type IV expression 
level in breast has made the result of this study 
important. Previous study has demonstrated by in situ 
hybridization and immunohistochemistry that α5(IV) 
and α6(IV)were defective in the invasive stages of 
breast cancer [25] and that the normal production 
as well as the basement membrane assembly was 
disrupted during cancer progression [27]. Thus the 
lower levels of collagen have been associated with 
the cancer mechanism of proliferation and 
metastasis [28, 29]. 
Collagen type IV was mainly expressed at basement 
membrane to constrain the cells from escaping out 
by encapsulated the tumor nest. By doing this, it 
produced irregular, dense and sheet-like deposition 
at basement membrane [30]. A series of structural 
changes based on type IV collagen uncoiling for 
degradation were developed thus indicates the 
importance of this collagen during tumorgenesis. 
 
 
4.0  CONCLUSION 
 
This study has established the mRNA expression assay 
using real-time PCR and represents an effort to 
quantify the level of COL4A1-COL4A6 mRNa chain of 
type IV collagen in breast cancer cell lines.  
The results of the study imply that the collagen 
expression was altered in the cancer cell lines 
because certain network of the type IV chain (α1-α6) 
was observed in a low amount as compared to its 
composition in normal breast cell that been reported 
in the literature.  
Previous study has suggested that structural 
change in collagen leads to modification of the 
cancer cells since its morphology is different at 
difference stages [31]. Therefore future study 
involving collagen type IV chains is sought to 
determine whether a change in the expression would 
be also observed in its secretion in extracellular 
membrane of the cell at protein level.  
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